| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.002 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.006 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.009 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |